Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice

Addiction Biology

Volumn 18, Issue 1, 2013, Pages 1-7

  Boix, Fernando ^a   Andersen, Jannike M ^a   Mørland, Jørg ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

6 monoacetylmorphine; blood brain transfer; heroin; mice; morphine; pharmacokinetic

Indexed keywords

DIAMORPHINE; MORPHINE; MORPHINE 6 ACETATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG METABOLISM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AREA UNDER CURVE; BLOOD-BRAIN BARRIER; BRAIN; HEROIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MICE; MODELS, BIOLOGICAL; MORPHINE; MORPHINE DERIVATIVES; NARCOTICS; SPECIMEN HANDLING; TISSUE DISTRIBUTION;

EID: 84871801693     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00298.x     Document Type: Article

References (20)

1. Andersen JM, Ripel A, Boix F, Normann PT, Morland J, (2009) Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a pro-drug for the mediator, 6-monoacetylmorphine, in vivo. J Pharmacol Exp Ther 331: 153-161.
2. Bardo MT, Rowlett JK, Harris MJ, (1995) Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19: 39-51.
3. Crow JA, Middleton BL, Borazjani A, Hatfield MJ, Potter PM, Ross MK, (2008) Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages. Biochim Biophys Acta 1781: 643-654.
4. Hand TH, Stinus L, Le Moal M, (1989) Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology (Berl) 98: 61-67.
5. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ, (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 33 (Suppl. 1): 773-776.
6. Kamendulis LM, Brzezinski MR, Pindel EV, Bosron WF, Dean RA, (1996) Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases. J Pharmacol Exp Ther 279: 713-717.
7. Karinen R, Andersen JM, Ripel A, Hasvold I, Hopen AB, Morland J, Christophersen AS, (2009) Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography-tandem mass spectrometry. J Anal Toxicol 33: 345-350.
8. Lockridge O, Mottershaw-Jackson N, Eckerson HW, La Du BN, (1980) Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. J Pharmacol Exp Ther 215: 1-8.
9. Martin WR, Fraser HF, (1961) A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther 133: 388-399.
10. Oldendorf WH, Hyman S, Braun L, Oldendorf SZ, (1972) Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 178: 984-986.
11. Rook EJ, Huitema AD, van den Brink W, Van Ree JM, Beijnen JH, (2006) Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol 1: 109-118.
12. Salmon AY, Goren Z, Avissar Y, Soreq H, (1999) Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine. Clin Exp Pharmacol Physiol 26: 596-600.
13. Satoh T, Taylor P, Bosron WF, Sanghani SP, Hosokawa M, La Du BN, (2002) Current progress on esterases: from molecular structure to function. Drug Metab Dispos 30: 488-493.
14. Schinkel AH, (1999) P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36: 179-194.
15. Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR, (2001) [mu] Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine. Biochem Pharmacol 62: 447-455.
16. Smith GM, Beecher HK, (1962) Subjective effects of heroin and morphine in normal subjects. J Pharmacol Exp Ther 136: 47-52.
17. Strandberg JJ, Kugelberg FC, Alkass K, Gustavsson A, Zahlsen K, Spigset O, Druid H, (2006) Toxicological analysis in rats subjected to heroin and morphine overdose. Toxicol Lett 166: 11-18.
18. Warburton H, Turnbull PJ, Hough M, (2005) Occasional and Controlled Heroin Use. Not a Problem? London: Joseph Rowntree Foundation. Drug and alcohol research programme.
19. Way EL, Kemp JW, Young JM, Grassetti DR, (1960) The pharmacologic effects of heroin in relationship to its rate of biotransformation. J Pharmacol Exp Ther 129: 144-154.
20. Zhou SF, (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38: 802-832.